Statistics
Publications
3
Citations
156
H-Index
3
Active since
2014
Affiliations
Osaka International Cancer Institute(Current)
Risa Kamada is an author at Osaka International Cancer Institute specializing in malignant neoplasms, cancer pharmacology, and cardiovascular toxicity assessment.
Publications per year
2014–2020
3
3
Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib
Kei Kunimasa, Risa Kamada, Toru Oka et al. · JACC CardioOncology · 2020 · 83 citations · Full text
Medicine, Oncology, Pharmacotherapy +15
Kei Kunimasa, Toru Oka, Satoshi Hara et al. · Lung Cancer · 2020 · 43 citations
Medicine, Oncology, Pharmacology +11
1–3 of 3